RS

Rekha Soni

Active Director Director DIN 00779058
DIN 00779058 First appointment Feb 2006 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2006
Shareholding value •••• Premium profile

About Rekha Soni

Data last updated:

Rekha Soni is a Director at Super Biotech Private Limited (since 2006). The company operates in Trading. Super Biotech Private Limited reported revenue of ₹99,235 (FY 2025).

DIN 00779058
Primary Designation Director
Industry Trading
First Appointment 20 Feb 2006
Oldest Company Age 21 yrs
Largest company Super Biotech Private Limited · ₹99,235 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Super Biotech Private Limited U74899DL2005PTC141265
Director20 Feb 20062005₹99,235 (FY 2025)Active

Board colleagues of Rekha Soni

NameDINCompanyDesignation
Devinder Kumar Soni00940687Super Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Super Biotech Private Limited
Premium access

Shareholding and investment profile for Rekha Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Soni

Rekha Soni currently holds 1 directorship: Super Biotech Private Limited (Director, since 20 Feb 2006, revenue ₹99,235 (FY 2025)).

Rekha Soni was first appointed on 20 Feb 2006 as Director at Super Biotech Private Limited.

The current boards of Rekha Soni's companies include Devinder Kumar Soni (Super Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available